FindTrial
Sign In

A retrospective study of the association between gene pathways and prognosis in soft tissue sarcoma and melanoma

A retrospective study of the association between gene pathways and prognosis in soft tissue sarcoma and melanoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094591
Enrollment
Unknown
Registered
2024-12-25
Start date
2024-12-27
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcoma, melanoma

Interventions

Grouping based on gene mutation subtypes and pathological subtypes:None

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with sarcoma and malignant melanoma were treated in our center. NGS testing or first generation sequencing or pcr testing had been performed previously.

Exclusion criteria

Exclusion criteria: Patients without sarcoma or malignant melanoma. Patients without genetic testing.

Design outcomes

Primary

MeasureTime frame
OS, PFS;—

Secondary

MeasureTime frame
Differences in survival between groups with different gene mutations;—

Countries

China

Contacts

Public ContactQian Wenkang

Zhejiang Cancer Hospital

qianwk@zjcc.org.cn+86 571 88128082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026